OnKure Therapeutics, Inc.
OKUR
$4.07
$0.174.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.14% | 4.49% | 3.36% | 8.70% | -50.93% |
| Total Depreciation and Amortization | -0.98% | -3.77% | 0.00% | 1.92% | 34.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -88.98% |
| Total Other Non-Cash Items | 2.02% | 1.89% | 5.94% | 1.40% | 3,415.58% |
| Change in Net Operating Assets | 18.01% | -49.90% | 3.18% | 88.27% | -1,749.44% |
| Cash from Operations | 11.70% | 1.79% | 5.22% | 40.03% | -119.06% |
| Capital Expenditure | -50.00% | 53.85% | 27.78% | -20.00% | 16.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -50.00% | 53.85% | 27.78% | -100.11% | 88,488.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 1,177,540.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -100.15% | -- |
| Cash from Financing | -- | -- | 100.00% | -100.07% | 2,204,820.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.51% | 1.84% | 5.77% | -113.72% | 1,063.11% |